Cytostatic mechanism and antitumor potential of novel 1H-cyclopenta[b]benzofuran lignans isolated from Aglaia elliptica

Chemico-Biological Interactions

Volumn 115, Issue 3, 1998, Pages 215-228

  Lee, Sang Kook ^a   Cui, Baoliang ^a   Mehta, Rajeshwari R ^b   Kinghorn, A Douglas ^a   Pezzuto, John M ^a,b  

^a Chicago College of Pharmacy   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

1H Cyclopenta b benzofuran lignans; Antitumor activity; Cell cycle; Cytostatic activity; Protein synthesis inhibition

Indexed keywords

BENZOFURAN DERIVATIVE; LEUCINE; LIGNAN; TRITIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSTASIS; DYNAMICS; HUMAN; HUMAN CELL; LUNG CARCINOMA; NONHUMAN; NUDE MOUSE; PLANT; PROTEIN SYNTHESIS INHIBITION;

AGLAIA ELLIPTICA; MELIACEAE;

EID: 0032476106     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(98)00073-8     Document Type: Article

References (27)

1. Cragg G.M., Newman D.J., Snader K.M. Natural products in drug discovery and development. J. Nat. Prod. 60:1997;52-60.
2. Baker J.T., Borris R.P., Carte B. et al. Natural product drug discovery and development: new perspectives on international colloboration. J. Nat. Prod. 58:1995;1325-1357.
3. G.M. Cragg, Role of plants in the National Cancer Institute Drug Discovery and Development Program, in: A.D. Kinghorn, M.F. Balandrin (Eds.), Human Medicinal Agents from Plants, ACS Symposium Series No. 534, American Chemical Society Books, Washington, DC, 1993, pp. 80-95.
4. M.E. Wall, M.C. Wani, Camptothecin and analogues: synthesis, biological in vitro and in vivo activities and clinical possibilities, in: A.D. Kinghorn, M.F. Balandrin (Eds.), Human Medicinal Agents from Plants, ACS Symposium Series No. 534, American Chemical Society Books, Washington, DC, 1993, pp. 149-169.
5. Pezzuto J.M. Plant-derived anticancer agents. Biochem. Pharmacol. 53:1997;121-133.
6. Cui B., Chai H., Santisuk T. et al. Novel cytotoxic 1H-cyclopenta[b]benzofuran lignans from Aglaia elliptica. Tetrahedron. 53:1997;17625-17632.
7. Ishibashi F., Satasook C., Isman M.B., Towers G.H.N. Insecticidal 1H-cyclopentatetrahydro[b]benzofurans from Aglaia odorata. Phytochemistry. 32:1993;307-310.
8. Janprasert J., Satasook C., Sukumalanand P. et al. Rocaglamide, a natural benzofuran insecticide from Aglaia odorata. Phytochemistry. 32:1993;67-69.
9. Ko F.-N., Wu T.-S., Liou M.-J., Huang T.-F., Teng C.-M. PAF antagonism in vitro and in vivo by aglafolin from Aglaia elliptifolia Merr. Eur. J. Pharmacol. 218:1992;129-135.
10. Wu T.-S., Liou M.-J., Kuoh C.-S., Teng C.-M., Nagao T., Lee K.-H. Cytotoxic and antiplatelet aggregation principles from Aglaia elliptifolia. J. Nat. Prod. 60:1997;606-608.
11. Ohse T., Ohba S., Yamamoto T., Koyano T., Umezawa K. Cyclopentabenzofuran lignan protein synthesis inhibitors from Aglaia odorata. J. Nat. Prod. 59:1996;650-652.
12. Likhitwitayawuid K., Angerhofer C.K., Cordell G.A., Pezzuto J.M., Raungrungsi N. Cytotoxic and antimalarial alkaloids from tubers of Stephania pierrei. J. Nat. Prod. 58:1993;1468-1478.
13. Shieh H.-L., Pezzuto J.M., Cordell G.A. Evaluation of the cytotoxic mechanisms mediated by the broad-spectrum antitumor alkaloid acronycine and selected semisynthetic derivatives. Chem. Biol. Interact. 81:1992;35-55.
14. Pisha E., Chai H., Lee I.-S. et al. Discovery of betulinic acid as a selective inhibitor of human melanoma that functions by induction of apoptosis. Nat. Med. 1:1995;1046-1051.
15. Baer M.R., Gao X.Z., Preisler H.D. Sustained viability of acute myelogenous leukemia cells in liquid suspension culture correlates with occurrence of differentiation. Leuk. Res. 12:1988;647-750.
16. Duh C.-Y., Kinghorn A.D., Pezzuto J.M. Cell-cycle specific cytotoxicity mediated by stizophyllin (2α,3β,12β-trihydroxypregna-4,7,16-trien-20-one), a novel electrophilic pregnane isolated from Stizophyllum riparium. Chem. Biol. Interact. 80:1991;43-56.
17. Mehta R.R., Graves J.M., Shilkaitis A., Hart G.D., Das Gupta T.K. Breast carcinoma cell lines with metastatic potential in mice. Int. J. Oncol. 6:1995;731-736.
18. Mehta R.R., Bratescu L., Graves J.M. et al. Human breast carcinoma cell lines: ultrastructural, genotypic, and immunocytochemical characterization. Anticancer Res. 12:1992;683-692.
19. Shamon L.A., Pezzuto J.M., Graves J.M. et al. Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett. 112:1997;113-117.
20. Houlihan W.J., Munder P.G., Handley D.A., Cheon S.H., Parrino V.A. Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines. J. Med. Chem. 38:1995;234-240.
21. Aviram A., Rephaeli A., Shaklai M. et al. Effect of the cytostatic butyric acid pro-drug, pivaloyloxymethyl butyrate, on the tumorigenicity of cancer cells. J. Cancer Res. Clin. Oncol. 123:1997;267-271.
22. Rephaeli A., Nordenberg J., Aviram A. et al. Butyrate induced differentiation in leukemic myeloid cells; in-vitro and in-vivo studies. Int. J. Oncol. 4:1994;1-5.
23. Vilpo J.A., Vilpo L.M., Vuorinen P., Moilanen E., Metsa-Ketela T. Mode of cytostatic action of mesoionic oxatriazole nitric oxide donors in proliferating human hematopoietic cells. Anti-Cancer Drug Des. 12:1997;75-89.
24. Cragg G., Suffness M. Metabolism of plant-derived anticancer agents. Pharmacol. Ther. 37:1988;425-461.
25. Huang M.-T. Harringtonine, an inhibitor of protein biosynthesis. Mol. Pharmacol. 11:1975;511-519.
26. Ling Y.-H., Tseng M.T., Harty J.I. Effects of homoharringtonine on protein glycosylation in human bladder carcinoma cell T-24. Cancer Res. 49:1989;76-80.
27. Zhou J.-Y., Chen D.-L., Shen Z.-S., Koeffler H.P. Effect of homoharringtonine on proliferation and differentiation of human leukemic cells in vitro. Cancer Res. 50:1990;2031-2035.